1 / 52

ARRITMIAS Ignacio Fernández Lozano. Javier Alzueta.

ARRITMIAS Ignacio Fernández Lozano. Javier Alzueta. Estratificación de riesgo. Incidencia de Muerte súbita. Myerburg RJ. Circulation .1998;97:1514-1521. GROUP. Población global. >2 factores de riesgo. Pacientes con enfermedad coronaria. Pacientes con FE <35%, e ICC.

hertz
Download Presentation

ARRITMIAS Ignacio Fernández Lozano. Javier Alzueta.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ARRITMIAS Ignacio Fernández Lozano.Javier Alzueta.

  2. Estratificación de riesgo

  3. Incidencia de Muerte súbita Myerburg RJ. Circulation.1998;97:1514-1521. GROUP Población global >2 factores de riesgo Pacientes con enfermedad coronaria Pacientes con FE <35%, e ICC Pacientes con PCR previa Pacientes con IAM FE deprimida y TV 0 0 100,000 200,000 300,000 5 10 20 25 30 Incidencia de MS(% grupo) Nº. De MS anual

  4. Hazard ratio for mortality among ICD recipients vs controls in the MADIT-2 non-VHR population (n=1131)a a. Non-very-high-risk patients, all those without a baseline BUN >50 mg/dL or serum creatinine >2.5 mg/dL b. NYHA class 3 or 4, atrial fibrillation, QRS interval >120 ms, age > 70 years, and BUN >26 mg/dL Goldenberg I et al. J Am Coll Cardiol 2008:51:288-296.

  5. DANAMI 2: 1.017 pac

  6. 1.041 pac post IAM. Jp

  7. 1.041 pac post IAM. Jp

  8. 446 pac YHA II/III

  9. MASTER I: Primary end point Chow T. American Heart Association 2007 Scientific Sessions; November 6, 2007; Orlando, FL.

  10. MASTER I: Mortality results *Hazard ratio for total mortality=2.04 95% CI=1.10-3.78 p=0.02 Chow T. American Heart Association 2007 Scientific Sessions; November 6, 2007; Orlando, FL.

  11. 179 pac MCD It

  12. 49 pac pre DAI

  13. 113 MS.

  14. High energy implant rates pmp Source: Eucomed

  15. 11.275 pac.

  16. 6.879 pac

  17. QT LARGO - CORTO

  18. 77 pr 513 fam. Nd Sensibilidad 72% Especificidad 86%

  19. 2000/7 pac

  20. QT < 320, QTc < 340 ms. 29 pacientes. It y Fr

  21. Sd BRUGADA

  22. SINCOPE

  23. 392 pacientes. Europa

  24. FA

  25. 2.824 pacientes. Sw

  26. EURIDIS + ADONIS 1.437 pac MM

  27. Ablación

  28. Grupo control (11) 60 a.C.. EEUU Grupo abl (48)

  29. 128 pac EEUU

  30. 128 pac EEUU

  31. 104 pac Fr

  32. FA par o per. 137 pac It

  33. 15 pac Al

  34. 57 pac Nd

More Related